Neurocrine Biosciences Inc. (NBIX)
Neurocrine Biosciences Inc. (NBIX) Insider Trading
Directors, officers and holders of more than 10% of NBIX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 554 transactions on file: 0 with code P, 15 with code S and 35 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 1,226 | $164.74 | $201,971 |
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 1,300 | $168.53 | $219,092 |
| Nov 3, 2026 | MORROW GEORGE J | Director | M Exercise | 7,200 | Not measured | Not measured |
| Nov 3, 2026 | MORROW GEORGE J | Director | M Exercise | 7,200 | $53.64 | $386,208 |
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 908 | $165.71 | $150,461 |
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 1,466 | $166.77 | $244,492 |
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 100 | $162.05 | $16,205 |
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 1,500 | $167.72 | $251,587 |
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 600 | $163.71 | $98,225 |
| Nov 3, 2026 | MORROW GEORGE J | Director | S Sale | 100 | $158.18 | $15,818 |
| Nov 2, 2026 | MORROW GEORGE J | Director | S Sale | 1,300 | $146.76 | $190,783 |
| Nov 2, 2026 | MORROW GEORGE J | Director | S Sale | 1,900 | $144.98 | $275,453 |
| Nov 2, 2026 | MORROW GEORGE J | Director | S Sale | 4,300 | $145.86 | $627,194 |
| Nov 2, 2026 | MORROW GEORGE J | Director | M Exercise | 7,500 | Not measured | Not measured |
| Nov 2, 2026 | MORROW GEORGE J | Director | M Exercise | 7,500 | $53.64 | $402,300 |
| Nov 1, 2026 | Gano Kyle | Chief Executive Officer | M Exercise | 614 | Not measured | Not measured |
| Nov 1, 2026 | Gano Kyle | Chief Executive Officer | M Exercise | 614 | Not measured | Not measured |
| Nov 1, 2026 | Gano Kyle | Chief Executive Officer | F Tax Payment | 332 | $146.10 | $48,505 |
| Oct 30, 2026 | MORROW GEORGE J | Director | M Exercise | 300 | $53.64 | $16,092 |
| Oct 30, 2026 | MORROW GEORGE J | Director | S Sale | 300 | $149.00 | $44,700 |
| Oct 30, 2026 | MORROW GEORGE J | Director | M Exercise | 300 | Not measured | Not measured |
| Sep 14, 2026 | Boyer David W. | Chief Corp. Affairs Officer | S Sale | 826 | $157.45 | $130,051 |
| Sep 14, 2026 | ABERNETHY MATT | Chief Financial Officer | S Sale | 2,311 | $157.20 | $363,285 |
| Sep 11, 2026 | Boyer David W. | Chief Corp. Affairs Officer | F Tax Payment | 1,936 | $156.22 | $302,442 |
| Sep 11, 2026 | ABERNETHY MATT | Chief Financial Officer | A Award | 5,020 | Not measured | Not measured |
| Sep 11, 2026 | Cooke Julie | Chief Human Resources Officer | A Award | 3,587 | Not measured | Not measured |
| Sep 11, 2026 | Onyia Jude | Chief Scientific Officer | F Tax Payment | 1,936 | $156.22 | $302,442 |
| Sep 11, 2026 | Cooke Julie | Chief Human Resources Officer | F Tax Payment | 1,936 | $156.22 | $302,442 |
| Sep 11, 2026 | Gano Kyle | Chief Executive Officer | A Award | 1,842 | Not measured | Not measured |
| Sep 11, 2026 | Gano Kyle | Chief Executive Officer | F Tax Payment | 3,386 | $156.22 | $528,961 |
| Sep 11, 2026 | Gano Kyle | Chief Executive Officer | F Tax Payment | 994 | $156.22 | $155,283 |
| Sep 11, 2026 | BENEVICH ERIC | Chief Commercial Officer | F Tax Payment | 3,386 | $156.22 | $528,961 |
| Sep 11, 2026 | GORMAN KEVIN CHARLES | Director | A Award | 14,343 | Not measured | Not measured |
| Sep 11, 2026 | Keswani Sanjay Chandru | Chief Medical Officer | A Award | 3,914 | Not measured | Not measured |
| Sep 11, 2026 | Delaet Ingrid | Chief Regulatory Officer | F Tax Payment | 2,419 | $156.22 | $377,896 |
| Sep 11, 2026 | Lippoldt Darin | Chief Legal Officer | A Award | 4,483 | Not measured | Not measured |
| Sep 11, 2026 | BENEVICH ERIC | Chief Commercial Officer | A Award | 6,275 | Not measured | Not measured |
| Sep 11, 2026 | Lippoldt Darin | Chief Legal Officer | F Tax Payment | 2,419 | $156.22 | $377,896 |
| Sep 11, 2026 | Boyer David W. | Chief Corp. Affairs Officer | A Award | 3,587 | Not measured | Not measured |
| Sep 11, 2026 | GORMAN KEVIN CHARLES | Director | F Tax Payment | 7,839 | $156.22 | $1,224,609 |
| Sep 11, 2026 | Keswani Sanjay Chandru | Chief Medical Officer | F Tax Payment | 2,112 | $156.22 | $329,937 |
| Sep 11, 2026 | Delaet Ingrid | Chief Regulatory Officer | A Award | 4,483 | Not measured | Not measured |
| Sep 11, 2026 | ABERNETHY MATT | Chief Financial Officer | F Tax Payment | 2,709 | $156.22 | $423,200 |
| Sep 11, 2026 | Gano Kyle | Chief Executive Officer | A Award | 6,275 | Not measured | Not measured |
| Sep 11, 2026 | Onyia Jude | Chief Scientific Officer | A Award | 3,587 | Not measured | Not measured |
| Sep 9, 2026 | BENEVICH ERIC | Chief Commercial Officer | S Sale | 2,154 | $154.61 | $333,030 |
| Sep 9, 2026 | BENEVICH ERIC | Chief Commercial Officer | M Exercise | 3,194 | $43.24 | $138,109 |
| Sep 9, 2026 | BENEVICH ERIC | Chief Commercial Officer | M Exercise | 3,194 | Not measured | Not measured |
| Sep 2, 2026 | SHERWIN STEPHEN A | Director | G Gift | 1,000 | Not measured | Not measured |
| Aug 4, 2026 | Onyia Jude | Chief Scientific Officer | G Gift | 2,409 | Not measured | Not measured |
The full Form 4 history is on the NBIX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.